Findings could pave the way for more personalized treatments for cardiovascular disease.

Siga Technologies' antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among ...

As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...

So there’s talk that Robert F. Kennedy Jr will defund the NIH.  Or something like that.  In full disclosure, I am not a fan of the man.  But, I also view the hysteria of academics and ...

Bhattacharya was one of the authors of the controversial Great Barrington Declaration, which in October 2020 condemned ...

While disruption is likely if nominee for NIH Director, Bhattacharya, is confirmed by the Senate, the kinds of changes the ...

President-elect Donald Trump has nominated Dr. Jay Bhattacharya to head the National Institutes of Health, a move that has ...

Jay Bhattacharya would consider the academic freedom at universities and medical schools applying for NIH research grants.

DONALD TRUMP’S ANNOUNCEMENT last month of Stanford professor Dr. Jay Bhattacharya as his nominee to be the next director of ...

Interim data from a phase 3 study evaluating tecovirimat for the treatment of human mpox virus showed the antiviral did not improve time to lesion resolution compared with placebo.

The letter Tuberville signed says the senators “oppose taxpayer funding going toward gender transition interventions for ...

President-elect Donald Trump has nominated Dr. Jay Bhattacharya to head the National Institutes of Health, a move that has ...